Retroperitoneal teratoma is a germ cell tumor derived from all three germ layers (ectoderm, mesoderm, endoderm) representing ectopic differentiation of pluripotent primordial germ cells. The coexistence of fat, calcification, and cystic components (teratoma triad) is diagnostically valuable and pathognomonic on CT — no other retroperitoneal tumor shows these three different density components together within the same mass. Mature (benign) form contains fully differentiated tissue components with excellent prognosis; immature (malignant potential) form contains embryonal tissue elements (especially neural tissue) with treatment planned according to grading system. Most common retroperitoneal germ cell tumor in childhood, with sacrococcygeal region and retroperitoneum as most common adult locations. AFP and beta-hCG tumor markers should be in normal range in mature teratoma; elevation suggests malignant germ cell component.
Age Range
10-45
Peak Age
25
Gender
Female predominant
Prevalence
Rare
Teratoma originates from primordial germ cells — these cells normally migrate to the gonadal ridge during early embryonic development but some may become trapped in ectopic locations along the migration path (retroperitoneum, mediastinum, pineal region, sacrococcygeal area). Trapped germ cells show differentiation into all three germ layers due to pluripotent capacity, explaining the coexistence of different tissue types. Ectodermal component (skin, hair, sebaceous glands, neural tissue → fat and keratinous material), mesodermal component (cartilage, bone, muscle, adipose → calcification and osseous structures), endodermal component (respiratory epithelium, GI epithelium, thyroid tissue → mucinous cystic areas) coexist. This triad creates pathognomonic CT appearance: fat density (-30 to -120 HU reflecting sebaceous material and adipose tissue), calcification (>100 HU, mature bone or dental structures), and cystic fluid (0-20 HU, serous or mucinous secretion). In immature teratoma, embryonal tissue components are present — especially neuroepithelial tissue (primitive neural tubes, neuroepithelial rosettes) is the main marker of immaturity with grading (Grade 0-3) based on neural tissue proportion. Immature neural tissue shows high vascularity and active proliferation → appears as enhancing solid component on CT/MRI.
Coexistence of fat density (-30 to -120 HU), calcification/bone (>100 HU), and cystic fluid (0-20 HU) within same mass is pathognomonic for teratoma and not seen in any other retroperitoneal tumor. Visualization of dental structures confirms diagnosis.
On non-contrast CT, teratoma triad: fat density (-30 to -120 HU), calcification/osseous structures (>100 HU), and cystic fluid (0-20 HU) within the same mass. This triad is pathognomonic. Fat-fluid levels may be seen. Mature bone or dental structures provide definitive diagnosis. ROI measurement confirming fat density is critical for differential diagnosis.
Report Sentence
A mass containing fat (-80 HU), calcification, and cystic components is seen in the retroperitoneal space consistent with teratoma triad.
On T1, fat component within teratoma shows high signal and signal loss on fat-suppressed sequences (STIR or chemical-selective fat-sat) confirms fat presence. Cystic fluid shows low T1, calcifications show signal void. Fat-fluid level is prominently seen on T1. Bone and cartilage components show low-intermediate signal with short T1.
Report Sentence
A high signal component on T1 with signal loss on fat suppression is seen; intralesional fat confirmed.
On T2, teratoma shows markedly heterogeneous signal. Cystic components very high T2 (free water → long T2), fat components intermediate-to-high T2, calcified areas signal void (T2* dominant shortening), and solid areas intermediate T2. This heterogeneous T2 pattern is the MRI correlate of the teratoma triad.
Report Sentence
The mass shows markedly heterogeneous T2 signal with cystic, fatty, calcified, and solid components.
On contrast-enhanced CT, solid components of mature teratoma show minimal enhancement because mature tissues have low vascularity. Immature teratoma solid components show more intense and heterogeneous enhancement — immature neural tissue contains rich neovascularization. Enhancement degree correlates with immaturity and malignancy potential. Cystic walls and septa may show thin enhancement.
Report Sentence
Minimal enhancement in solid components consistent with mature teratoma.
On US, teratoma appears as a complex cystic mass. Echogenic foci with posterior acoustic shadowing represent calcifications (bone/dental structures). Echogenic areas represent fat component. Dermoid mesh/plug (hair + sebaceous material ball) is described especially in ovarian dermoids and rarely seen in retroperitoneum. Posterior enhancement seen in cystic areas.
Report Sentence
A complex cystic mass on US with echogenic foci (calcification) and echogenic areas (fat) consistent with teratoma.
On DWI, cystic compartments in mature teratoma show free diffusion (high ADC). Neural tissue components in immature teratoma may show diffusion restriction because high cellular density narrows extracellular space. Keratinous material (dermoid plug) may give bright DWI signal (epidermoid cyst-like pattern). DWI may help differentiate mature and immature components.
Report Sentence
Free diffusion in cystic compartments on DWI without restriction in solid components; consistent with mature teratoma.
Criteria
Completely mature tissue components, no mitotic activity — excellent prognosis
Distinct Features
Well-defined, minimal enhancement, prominent fat-calcification-cyst triad, complete surgical resection curative; AFP and beta-hCG normal
Criteria
Immature embryonal tissue (especially neural), grading Grade 0-3 — malignancy potential
Distinct Features
More prominent solid component with more intense enhancement, diffusion restriction in solid components on DWI, requires adjuvant chemotherapy (BEP regimen); most aggressive in Grade 3
Criteria
Somatic malignancy on mature teratoma background (SCC, adenocarcinoma, sarcoma) — rare, in adults
Distinct Features
Aggressive solid component, rapid growth, necrosis, invasion, intense enhancement; surgery + adjuvant treatment based on somatic malignancy type
Distinguishing Feature
Epidermoid cyst does NOT contain fat density or calcification, appearing as homogeneous low-density unilocular cyst; teratoma shows pathognomonic triad (fat + calcification + cyst). Definitive differentiation by CT densitometry.
Distinguishing Feature
Xanthogranuloma is fat-negative (does NOT contain macroscopic fat, all voxels >0 HU); teratoma contains macroscopic fat density (-30 to -120 HU). ROI measurement confirming fat density provides definitive differentiation.
Distinguishing Feature
Abscess shows rim enhancement, gas, clinical infection; teratoma shows fat-calcification triad, no infection findings. Gas presence strongly supports infected collection, while fat + calcification triad strongly supports teratoma.
Distinguishing Feature
Liposarcoma contains macroscopic fat but does NOT contain calcification/bone structure and cystic component; solid enhancing nonadipose component (dedifferentiated) may be dominant. Teratoma shows triad (fat + calcification + cyst) and calcification/dental structures are not seen in liposarcoma.
Urgency
routineManagement
surgicalBiopsy
Not NeededFollow-up
12-monthComplete surgical resection is curative in mature teratoma with 5-year survival over 99%. AFP and beta-hCG tumor markers should be checked preoperatively — elevated values suggest malignant germ cell component (yolk sac tumor, choriocarcinoma) and change treatment plan. Immature teratoma requires surgery + adjuvant chemotherapy (BEP regimen: bleomycin, etoposide, cisplatin). Recurrence in mature teratoma is very rare, related to incomplete resection. Close follow-up needed in immature teratoma — CT and tumor markers every 3-6 months. In malignant transformation, treatment determined by somatic malignancy type.
Mature teratoma is benign and surgical resection is curative. Immature teratoma carries malignant potential and may require chemotherapy. AFP and β-hCG levels should be checked to assess for malignant component. Prognosis is excellent if tumor markers are normal.